David Boldt • UCLA Profiles

David Warren Boldt

Title(s)	HS Associate Clinical Professor, Anesthesiology
School	Medicine
vCard	Download vCard

ORNG Applications

Clinical Trials

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock. Ann Intensive Care. 2023 Dec 16; 13(1):128. Leisman DE, Handisides DR, Chawla LS, Albertson TE, Busse LW, Boldt DW, Deane AM, Gong MN, Ham KR, Khanna AK, Ostermann M, McCurdy MT, Thompson BT, Tumlin JS, Adams CD, Hodges TN, Bellomo R. PMID: 38103056; PMCID: PMC10725390.

View in: PubMed Mentions:
Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States. Ren Fail. 2023; 45(2):2290932. Boldt D, Busse L, Chawla LS, Flannery AH, Khanna A, Neyra JA, Palmer P, Wilson J, Yessayan L. PMID: 38073554.

View in: PubMed Mentions: Fields:
Nep Nephrology
Translation:Humans
Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial. Crit Care. 2023 05 05; 27(1):175. Wieruszewski PM, Bellomo R, Busse LW, Ham KR, Zarbock A, Khanna AK, Deane AM, Ostermann M, Wunderink RG, Boldt DW, Kroll S, Greenfeld CR, Hodges T, Chow JH, Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators. PMID: 37147690; PMCID: PMC10163684.

View in: PubMed Mentions: 7 Fields:
Cri Critical Care
Translation:Humans
Norepinephrine versus phenylephrine for treating hypotension during general anaesthesia in adult patients undergoing major noncardiac surgery: a multicentre, open-label, cluster-randomised, crossover, feasibility, and pilot trial. Br J Anaesth. 2023 05; 130(5):519-527. Legrand M, Kothari R, Fong N, Palaniappa N, Boldt D, Chen LL, Kurien P, Gabel E, Sturgess-DaPrato J, Harhay MO, Pirracchio R, Bokoch MP, VEGA-1 trial investigators. PMID: 36925330.

View in: PubMed Mentions: Fields:
Ane Anesthesiology
Translation:Humans
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial. Am J Respir Crit Care Med. 2020 11 01; 202(9):1253-1261. Bellomo R, Forni LG, Busse LW, McCurdy MT, Ham KR, Boldt DW, Hästbacka J, Khanna AK, Albertson TE, Tumlin J, Storey K, Handisides D, Tidmarsh GF, Chawla LS, Ostermann M. PMID: 32609011; PMCID: PMC7605187.

View in: PubMed Mentions: 55 Fields:
Cri Critical Care Pul Pulmonary Medicine
Translation:Humans CTClinical Trials
Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial. Ann Intensive Care. 2019 Jun 03; 9(1):63. Ham KR, Boldt DW, McCurdy MT, Busse LW, Favory R, Gong MN, Khanna AK, Chock SN, Zeng F, Chawla LS, Tidmarsh GF, Ostermann M. PMID: 31161442; PMCID: PMC6546778.

View in: PubMed Mentions: 13
Angiotensin in ECMO patients with refractory shock. Crit Care. 2018 Nov 01; 22(1):288. Ostermann M, Boldt DW, Harper MD, Lim GW, Gunnerson K. PMID: 30382926; PMCID: PMC6211436.

View in: PubMed Mentions: 7 Fields:
Cri Critical Care
Translation:Humans
Angiotensin II for the Treatment of Vasodilatory Shock. N Engl J Med. 2017 08 03; 377(5):419-430. Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, Busse LW, Altaweel L, Albertson TE, Mackey C, McCurdy MT, Boldt DW, Chock S, Young PJ, Krell K, Wunderink RG, Ostermann M, Murugan R, Gong MN, Panwar R, Hästbacka J, Favory R, Venkatesh B, Thompson BT, Bellomo R, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Deane AM, ATHOS-3 Investigators. PMID: 28528561.

View in: PubMed Mentions: 208 Fields:
Med Medicine (General)
Translation:Humans
Teaching suturing in a workshop setting: a comparison of several models. Hawaii Med J. 2004 Sep; 63(9):258-9. Tokuhara KG, Boldt DW, Yamamoto LG. PMID: 15540520.

View in: PubMed Mentions: 8 Fields:
Med Medicine (General)
Translation:Animals
Problem based learning and medical malpractice: does how you've been trained make a difference? Hawaii Med J. 2003 Apr; 62(4):73-4, 77-9. Behling D, Low K, Severino R, Boldt DW, Hardman J. PMID: 12774674.

View in: PubMed Mentions: 1 Fields:
Med Medicine (General)
Translation:Humans
Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia. Br J Haematol. 2003 Mar; 120(6):1017-25. Hsi ED, Kopecky KJ, Appelbaum FR, Boldt D, Frey T, Loftus M, Hussein MA. PMID: 12648072.

View in: PubMed Mentions: 12 Fields:
Hem Hematology
Translation:Humans Cells